Gag virus-like particles (VLP) represent an interesting HIV vaccine component since they stimulate strong humoral and cellular immune responses. We demonstrated that VLP expressed by recombinant baculoviruses activate human PBMC to release pro-inflammatory (lL-6, TNF-α), anti-inflammatory (IL-10) and Th1-polarizing (IFN-γ) cytokines as well as GM-CSF and MIP-1α in a dose-and time-dependent manner. Herein, residual baculoviruses within the VLP preparations showed no or minor effects. Monocytes could be identified as a main target for VLP to induce cytokine production. Furthermore, VLP-induced monocyte activation was shown by upregulation of molecules involved in antigen presentation (MHC II, CD80, CD86) and cell adhesion (CD54). Exposure of VLP to serum inactivates its capacity to stimulate cytokine production. In summary, these investigations establish VLP as strong activators of PBMC and monocytes therein, potently enhancing their functionality and potency to promote an efficient immune response. This capacity makes VLP an interesting component of combination vaccines.
Introduction
A successful vaccination against human immunodeficiency virus (HIV) depends on an efficient activation of the innate immune response with the induction of an appropriate cytokine milieu and enhanced expression of functional surface molecules on antigenpresenting cells (APC). Despite current progress, the development of a safe and efficient HIV vaccine is still a major concern and a great challenge. In the last decade, virus-like particles (VLP) have been described as being superior to conventional protein immunogens in the activation of immune responses. For HIV, the Pr55
Gag (Gag) precursor protein has been reported by others and by our group to include all information allowing for self-assembly into highly organized lipoprotein particles. These VLP do not replicate, are not infectious and resemble native immature virions in terms of morphology and immunogenicity (Gheysen et al., 1989 , Vernon et al., 1991 , and Wagner et al., 1992 , for review, also see Young and Ross, 2003 and Deml et al., 2005) . They can be easily produced in large quantities by the baculovirus expression system where they are released from the producer cell by budding (Gheysen et al., 1989 , Royer et al., 1992 , and Wagner et al., 1996b . Vaccination with these VLP induces strong immune responses in mice (Griffiths et al., 1993 and Wagner et al. 1996b ) and non human primates (Wagner et al., 1996a , 1998 , Notka et al., 1999 and Paliard et al., 2000 , even in complete absence of additional adjuvants (for review, also see Young and Ross, 2003 , Deml et al., 2005 and Ludwig and Wagner 2007 . However the precise mechanisms of immune activation by VLP are still not fully understood and yet have been investigated only for dendritic cells (DCs) . Recently, Tsunetsugu-Yokota have provided evidence that yeast-derived HIV VLP induce DC maturation and enhanced cytokine production, notably IL-12p70 through the Toll-like receptor (TLR)-2 signalling pathway (Tsunetsugu-Yokota et al., 2003) . Furthermore Buonaguro et al. reported the maturation and activation of monocyte-derived DCs by baculovirus-produced Gag VLP through TLR-2 and-4 independent mechanisms (Buonaguro et al., 2006) . Herein we aimed to analyse the capacity of baculovirus-expressed VLP to stimulate innate immune responses in human PBMC and in particular to investigate VLP-mediated activation and maturation of monocytes. Indeed, monocytes are of special relevance for the initiation of immune responses, since they provide a suitable cytokine and chemokine environment for attracting immune cells and potent activation of T cell responses. In this study, we have demonstrated that VLP possess a strong capacity to initiate the release of a broad spectrum of pro-and antiinflammatory cytokines and chemokines from freshly isolated PBMC in a dose-dependent manner. Furthermore, monocytes considerably contribute to this VLP effect. In addition, VLP-pulsed monocytes show a significant upregulation of surface molecules playing an important role in the adhesion to endothelium, in phagocytosis and antigen presentation. These results strongly support the suitability of VLP for HIV vaccine purposes.
Results
Production and biochemical characterization of baculovirus-expressed HIV Gag VLP Virus-like particles composed of HIV Gag polyprotein (Fig. 1A) were expressed in HighFive™ insect cells. The Gag polyprotein consists of the functional p17 matrix protein, the p24 capsid protein, the p7 nucleocapsid protein and the late domain-containing protein p6 (Fig.  1A ). VLP were purified from the precleared culture supernatant of AcGag infected HighFive™ cells by sequential sedimentation through 30% sucrose cushions and separation of obtained antigens in 10 to 50% sucrose gradients. Identically purified antigens from uninfected and wild-type (wt) baculovirus-infected cells served as controls. Produced antigens were characterized by Coomassie staining (Fig. 1B) and immunoblotting (Fig. 1C) . Antigenic peak fractions derived from supernatants of Ac-Gag infected cells included a dominant band with an apparent molecular mass of 55 kDa, corresponding to that of the HIV Gag polyprotein (Figs. 1B and C, lane 3) . This band was not visible in antigen preparations from non infected (lane 1) and wt baculovirusinfected cells (lane 2). Analysis by Coomassie staining revealed a purity of produced VLP preparations of N85% (Fig. 1B ). Immunoblot analysis of purified particles using an anti-Gag antibody confirmed the identity of Gag protein (Fig. 1C) . Electron microscopy showed the presence of virus-like particles but also residual baculoviruses within the Gag antigen preparation (Fig. 1D) .
VLP induce a variety of immunomodulatory cytokines and chemokines in human PBMC
The capacity of baculovirus-expressed Gag VLP to modulate innate immune responses was analyzed in cultures of freshly isolated PBMC. Incubation of PBMC with VLP triggered the release of the proinflammatory cytokines IL-6, TNF-α and IFN-γ (Figs. 2A, C and E). These cytokines showed substantial differences in their secretion kinetics: a highly significant increase of IL-6 was already measurable after 6 h and the concentrations in the culture supernatant subsequently remained on a high level for more than 40 h ( Fig. 2A) . Elevated amounts of TNF-α were visible with a maximum peak 18 h after addition of VLP and decreased slightly over time (Fig. 2C) , whereas weak but continuously elevating levels of IFN-γ were measurable over 70 h post stimulation (Fig. 2E ). In addition, varying concentrations of VLP were necessary to achieve an induction of different cytokines: significant production of IL-6 was observed upon stimulation with 1.25 μg/ml VLP, whereas 5 μg/ml VLP were required to stimulate IFN-γ and TNF-α production. The amounts of IL-12 remained below the detection level during the monitored time period (Fig. 2G) .
The participation of residual baculoviruses within the VLP preparation in the induction of cytokine production was evaluated in parallel samples. Therefore, PBMC were stimulated with baculoviruses at concentrations adequate to that in VLP-pulsed cells (Figs. 2B, D, F and H) . Herein 1 μg VLP included approximately 1.44 × 10 6 infectious baculoviruses as determined by a plaque titration assay. A low contribution of baculovirus to the immunostimulatory effect of VLP preparations was shown for IL-6 (Fig. 2B ) and at late time points for IFN-γ (Fig. 2F ), but not for TNF-α (Fig. 2D) .
Similarly, pulsing of PBMC with VLP induced the secretion of the leukocyte growth factor GM-CSF, anti-inflammatory IL-10 and the chemokine MIP-1α as additional markers of immune activation (Figs. 3C, E and G), whereas the levels of IL-2 remained unaltered (Fig. 3A) . Increased concentrations of these cyto-/chemokines were visible already after 18 h (GM-CSF and MIP-1α) or 27 h (IL-10), respectively. The minimal VLP concentration required to achieve enhanced cytokine and chemokine release was 1.25 μg/ml for the latter three molecules. Again, stimulation of cells with baculoviruses at concentrations corresponding to that in the VLP preparations had no (IL-2, GM-CSF) or only a minor effects (IL-10) on the production of these signaling molecules in PBMC (Figs. 3B, D, F and H). Substantially increased concentrations were only detectable for MIP-1α after 50 and 70 h of stimulation with baculoviruses equivalent to that present in 12.5 μg/ml of the VLP preparation reaching approximately 50% of the maximum concentrations observed in VLP-stimulated cells.
These results underline the potent capacity of VLP to induce strong and rapid cytokine and chemokine responses in human PBMC. Residual baculoviruses in the VLP preparations did not or only marginally contribute to this effect. were quantified by ELISA. The cytokine levels are presented as mean ± SD from three parallel samples. 
Cellular activity of blood-derived cells in the presence of VLP or baculoviruses
To confirm the immunostimulatory properties of VLP in cultures of PBMC we used the MTS assay, which allows for investigation of metabolic cell activity (Fig. 4) . At concentrations of 5 μg/ml and 12.5 μg/ml VLP significantly enhanced the cellular activity as shown by conversion of the MTS compound (Fig. 4A ). Baculoviruses in concentrations equivalent to those in the VLP preparation also increased the metabolic activity of the cells, but the effect was less pronounced (Fig. 4B) .
Since monocytes represent an essential subpopulation of antigenpresenting cells (APC) within the PBMC with relevant capacity to activate and polarize immune activity we also evaluated the effect of VLP on this cell type. Again we found a significant increase of cellular activity after incubation with 5 μg/ml and 12.5 μg/ml VLP as shown by conversion of the MTS compound (Fig. 4C ). Parallel samples incubated with the equivalent amounts of baculoviruses demonstrated no or only a minor effect of the residual viruses within the VLP preparation on the enhancement of the metabolic activity (Fig. 4D ).
Cytokine and chemokine production in primary human monocytes incubated with VLP
Since the MTS experiments implied that monocytes represent a target of VLP stimulation within PBMC we evaluated the contribution of monocytes to the VLP-induced production of cytokines/chemokines by PBMC. Unlike PBMC, isolated monocytes did not reveal any significant production of IL-6 after stimulation with VLP ( Fig. 5A ). In contrast VLP-pulsed monocytes produced increased levels of TNF-α, IL-10, GM-CSF and MIP-1α (Figs. 5C, E, G and I). The precise kinetics and concentrations of released cyto-and chemokines differed from that observed for PBMC. The corresponding numbers of residual baculoviruses had nearly no effect on the production of IL-6, TNF-α and IL-10 (Figs. 5B, D and F). A minor effect was observed for monocytic synthesis of GM-CSF (Fig. 5H ) and more pronounced MIP-1α (Fig. 5K) .
Dose titration experiments with increasing concentrations of purified baculoviruses, ranging from 0.025 to 12.5 μg/ml showed, that even at high concentrations of 12.5 μg/ml baculoviruses do not induce any release of IL-10 from cultured monocytes after 24 h of incubation, whereas 2.5 μg/ml VLP were sufficient to induce significant IL-10 production (Fig. 6 ).
Expression of immunologically relevant maturation molecules on the surface of VLP-pulsed monocytes
Further experiments aimed to analyse the influence of VLP on the expression of monocytic surface molecules which are relevant for the antimicrobial activity of this cell type. Monocytes were incubated with increasing concentrations of VLP and the surface expression of the adhesion molecule CD54 which mediates the monocytic interaction with endothelial cells and subsequent penetration into the infected tissue, was evaluated by FACS. VLP strongly increased the expression of CD54 compared to medium-treated cells in a dose-dependent manner (Fig. 7) . Even incubation with the lowest concentration of 1 μg/ml resulted in an increase of the mean value from 83 to 113.5, and the FACS mean value of those cells incubated with the highest VLP concentration of 25 μg/ml was 242.4. Similarly, the percentage of cells within an arbitrary gate increased from 3.4% in the samples with medium to 46.1% in the samples pulsed with 25 μg/ml VLP. Baculoviruses revealed no effect on the surface signal for CD54 (data not shown).
In parallel experiments the expression of the co-stimulatory molecules CD80 and CD86 was analysed. The FACS mean value for CD80 was elevated in a concentration-dependent manner from 13.9 in medium-treated cells up to 33.2 in cells incubated with 25 μg/ml VLP; the percentage of cells within an arbitrary gate increased from 2.6% to 32% (Fig. 7) . The FACS mean value for CD86 was 39.5 for the cells treated with the highest VLP concentration compared to 15.1 in the medium control (28.1% of cells within an arbitrary gate versus 6.6%) (Fig. 7) . Again, corresponding amounts of residual baculoviruses did not change the surface expression of these two molecules (data not shown).
In addition the expression of CD11b, CD18, MHC I and MHC II was analysed in the presence of 25 μg/ml VLP. Both CD11b and CD18, which form the heterodimeric complement receptor 3 and thus enable phagocytic activity, were present in higher amounts on monocytes incubated with VLP compared to untreated control cells (FACS mean value 44.5 versus 31.6 for CD11b and 212.9 versus 97.3 for CD18, respectively; the corresponding percentages of cells within an arbitrary gate were 24.2% versus 7.4% for CD11b and 60.9% compared to 12.3% for CD18) (Fig. 8 ). An enhanced surface signal was also visible for the antigen-presenting molecule MHC I (FACS mean value 201.8 in the presence and 115.5 in the absence of VLP, or 78% compared to 48.7% of cells within an arbitrary gate) (Fig. 8) , whereas the expression of MHC II was unaltered (FACS mean value of 213.3 versus 195.3 in the control sample, or 30.8% versus 28% cells within an arbitrary gate) (Fig. 8) . Corresponding numbers of residual baculoviruses did not change the surface expression of any of these four molecules (data not shown).
Relevance of the intact VLP structure for their capacity to activate immune response
We investigated the relevance of the integrity of Gag VLP for their immunomodulatory characteristics. Whereas addition of VLP to monocytes resulted in enhanced secretion of IL-10 into the cell culture supernatant, the disintegration of the particles by the detergent NP-40 completely abolished this effect (Fig. 9A) . Similarly the immunomodulatory capacity of VLP could be largely disrupted by incubation in serum.
Since the serum-induced inactivation of the VLP may be of particular importance in vivo we analysed the kinetics for this process in more detail. VLP were still active to induce substantial IL-10 production after incubation in serum for 1 min, but almost completely failed to induce IL-10 secretion after pre-treatment in serum for 10 min or longer (Fig. 9B) . Similarly, pre-incubation of VLP for more than 10 min with serum is required to abolish the upregulation of TNF-α synthesis (Fig. 9D) , whereas a reduced capacity of VLP to stimulate IFN-γ production was observed already after 1 min of serum treatment (Fig.  9C) . Heat inactivation for 30 min at 56°C largely reversed the inhibitory effect of serum on the capacity of VLP to stimulate IL-10 production, indicating the role a heat-labile component (Fig. 9B) . Serum did not disturb the particulate structure of the particles since they showed unaltered sedimentation in sucrose gradients (data not shown).
Discussion
We and others have previously reported that baculovirusexpressed HIV Gag virus-like particles (VLP) reveal a strong capacity to induce T helper-1 (Th-1) cell-mediated humoral and cellular immune responses in complete absence of any co-administered immunostimulatory adjuvant (Wagner et al., 1996b , Paliard et al. 2000 .
Herein, we show that these VLP per se represent potent activators of innate immune responses as demonstrated by the induction of immunomodulatory cytokines such as IFN-γ, TNF-α, IL-6, IL-10 and GM-CSF and chemokines (MIP-1α) in VLP-pulsed PBMC of HIVseronegative blood donors. Moreover, we showed that VLP promote the activation and maturation of human monocytes, resulting in an increased secretion of pro (TNF-α)-and anti-inflammatory (IL-10) cytokines in addition the chemokine MIP-1α. VLP-pulsed monocytes showed substantially enhanced surface expression of CD54 and the maturation markers CD80, CD86 and MHC II, thus enhancing its capacity to activate antigen-specific T cells. Furthermore, VLP-induced stimulation of GM-CSF production from monocytes and PBMC promotes in a positive feedback loop the de novo generation of monocytes and granulocytes from stem cells. The observation that VLP-pulsed human PBMC and isolated monocytes produce a similar pattern of cyto-and chemokines indicates a major role of monocytes in VLP-induced activation of innate immune responses. However, observed differences in the kinetics and absolute concentrations of cytokines in cultures of VLP-stimulated PBMC and monocytes as well as the lack of IL-6 and IFN-γ in VLP-pulsed monocyte cultures strongly suggest that VLP activate different types of immune cells for cytokine production. This observation is in accordance with previous findings by others, reporting an efficient stimulation of dendritic cells (DC) by baculovirus-and yeast-derived Gag VLP (Buonaguro et al., 2006 , Tsunetsugu-Yokota et al. 2003 . These results show that baculovirusexpressed VLP support the establishment of an inflammatory and Th-1-polarizing cytokine milieu as well as the activation of APC.
These observations are in accordance with the capacity of VLP to induce strong Th-1-polarized humoral and cytotoxic T cell responses, which have been repeatedly demonstrated in VLP-vaccinated mice and non-human primates (Wagner et al., 1996a , Deml et al., 1997 , Notka et al., 1999 , Paliard et al., 2000 , Buonaguro, et al., 2002 . In addition, the strong intrinsic Th-1-polarizing adjuvant properties of VLP may also explain the capacity of VLP to induce enhanced Th-1-polarized antibody and CTL responses to particle-entrapped and coadministered synthetic peptides and soluble proteins (Wagner et al., /ml) were incubated with medium, 2.5 μg/ml VLP or increasing concentrations of baculovirus. Culture supernatants were harvested after 24 h and the amount of IL-10 therein were quantified by ELISA. The cytokine levels are presented as mean ± SD from three parallel samples. 1996b , 1998 , Deml et al., 1997 , Buonaguro et al., 2002 . Immunoactivation could be also demonstrated for both PBMC and monocytes as shown by an increase of the general metabolic activity of the cells. The reason for the delayed increase in metabolic activity in comparison to the release of cytokines is unclear. However, one explanation may be, that it is not directly mediated by VLP, but indirectly by released cytokines such as GM-CSF.
The immunostimulatory effects of baculovirus-expressed VLP resemble that of pathogen-associated molecular patterns (PAMPs) such as bacterial DNA containing unmethylated CpG-motifs (Sato et al., 1996 and Klinman et al., 1996) and lipopolysaccharide (LPS). These bacterial compounds have been described previously to trigger the activation of inflammatory and antimicrobial immune responses by Toll-like receptor signaling pathways (Hemmi et al., 2000 and Fig. 7 . Effect of increasing concentrations of purified VLP on surface expression of CD54, CD80 and CD86 on monocytes. Freshly isolated human monocytes (1 × 10 6 /ml) were incubated for 3 days at 37°C with medium or with increasing concentrations of purified VLP (1 to 25 μg/ml). The expression of CD54, CD80 and CD86 was monitored by FACS using specific antibodies (shaded area). As a control, non-specific binding of immunoglobulin of the same isotype was measured (white area). Hoshino et al., 1999) . It is likely that the VLP preparations include residual components of the expression system, which may contribute to the capacity of these complex particulate immunogens to act as a "danger signal" activating the innate immunity. Tsunetsugu-Yokota et al. reported that yeast-derived HIV Gag VLP induce maturation and enhanced cytokine production from dendritic cells. Internalisation of yeast-derived VLP by both macropinocytosis and endocytosis came along with the upregulation of CD83 and HLA-DR and an enhanced production of cytokines, particularly IL-12 and TNF-α {Tsunetsugu-Yokota et al., 2003}. Herein, yeast cell membranes were almost equally efficient as yeast-derived VLP regarding the stimulation of dendritic cell (DC) maturation. In contrast, production of cytokines by DC was only observed upon stimulation with yeast cell-derived VLP implicating that besides producer cell-derived membranes also other particle components may act as "danger signals" to activate DC by TLR engagement.
Similarly, baculovirus-expressed VLP include insect cell-and baculovirus-derived impurities such as lipids, nucleic acids and proteins, some of which have been previously described to support the activation of innate immune responses. For example, insect and baculovirus DNA reveal adjuvant activity to stimulate APC (Sun et al., 1997 , Abe et al., 2005 . In addition, contaminating baculoviruses and baculoviral Env proteins, in particular gp64 may also contribute to the observed immune activation properties of baculovirus-derived VLP. Herein we showed, that common methods of VLP purification by consecutive separation on sucrose cushions and gradients do not facilitate complete separation of baculoviruses resulting in traces of contaminating viruses within the VLP preparations. Baculoviruses /ml) were incubated for 3 days at 37°C with medium or with 12.5 μg/ml purified VLP. The expression of the surface molecules was monitored by FACS using specific antibodies (shaded area). As a control, non-specific binding of immunoglobulin of the same isotype was measured (white area). A typical monocyte preparation with approximately 96% purity is shown in (B). The gates indicate the distribution of monocytes (R1) and lymphocytes (R2).
represent potent inductors of innate cytokine production in murine and human cells (Gronowski et al., 1999 , Abe et al., 2003 . Accordingly, gp64-mediated uptake of baculoviruses and interaction of released baculoviral DNA with TLR 9 within endosomal compartments has been suggested to be necessary for the activation of innate immune responses (Abe et al., 2005) . We speculate that baculovirus-expressed VLP may stimulate innate immune responses by a similar mechanism as described for baculoviruses. This hypothesis is based on our observation, that VLP produced in the baculovirus system include high concentrations of the fusogenic baculovirus protein gp64. However, this hypothesis remains to be confirmed in future experiments.
In addition, we showed that disruption of VLP by the detergent NP-40 and incubation with human serum including active components of the complement substantially impedes the capacity of VLP to stimulate cytokine secretion as shown for IL-10, IFN-γ and TNF-α. Fig. 9 . Cytokine induction by VLP depending on its particular structure. (A) Freshly isolated human monocytes were incubated either with intact VLP, VLP pre-lysed in the detergent NP-40 or VLP pre-incubated with human serum. Medium-stimulated cells served as negative controls. Cell culture supernatants were harvested at different time points and the amount of IL-10 therein was determined by ELISA. The cytokine levels are presented as mean ± SD from three parallel samples. (B-D) Purified VLP (12.5 μg/ml) were given either directly to freshly isolated monocytes or were pre-incubated with serum for different time periods ranging from 1 min to 2 h. For one set of samples the serum was heated for 30 min at 56°C before addition of the VLP for further 30 min. Monocytes incubated only with medium or with serum in the absence of VLP served as negative controls. Cell culture supernatants were harvested after 16 h of incubation and IL-10 (B), IFN-γ (C) and TNF-α (D) were quantified by ELISA. Each bar represents the mean ± SD from three parallel samples.
The observation, that heat inactivated serum did not significantly alter implies a putative role of complement in particle disintegration since this temperature is typically used to inactivate the complement components. Unlike NP-40 treatment, perforation of VLP with complement did not significantly alter the sedimentation behavior in sucrose gradients (data not shown) indicating an unaltered particulate structure of complement-treated Gag VLP. However, both treatments may induce the release of nucleic acids from the particles, thus affecting its potency to activate cells of the innate immune system. These observations underline the importance of the particulate structure and composition of these complex antigens for its efficacy to activate innate immunity.
In contrast, we showed, that the residual baculoviruses within the VLP preparations contributed only to a minor extent to the immunostimulatory properties of baculovirus-expressed VLP since they induced only low levels of IL-6, IFN-γ and IL-10 in addition to a significant production of MIP-1α from human PBMC as well as poor concentrations of IL-6, IL-10 GM-CSF and MIP-1α from monocytes.
In summary, this study emphasizes the strong capacity of baculovirus-expressed VLP to stimulate innate immunity as a prerequisite for the induction of cell-mediated immune responses. A more detailed understanding of structural characteristics of VLP and the role of producer cell-derived components in the activation and polarization of innate immunity will lead to a rational improvement of the immunogenicity of VLP antigens for HIV vaccine purposes.
Materials and methods

Monoclonal antibodies
The monoclonal antibodies (mab) 16/4/2 and 13-5 have been previously mapped within the p24 (CA) moiety of the HIV Gag polyprotein (Wolf et al., 2008) . The capture and detection antibodies for ELISA recognizing IL-2, IL-6, IL-10, IL-12, TNF-α and GM-CSF were purchased from Pharmingen/Becton Dickinson (Franklin Lakes, USA); antibodies for the quantification of IFN-γ and MIP-1α were obtained from R&D Systems (McKinley Place, USA). The antibodies utilized for the detection of CD54, CD80 and CD86 by flow cytometry were obtained from Pharmingen/Becton Dickinson and the IgG control antibody was purchased from Dako (Hamburg, Germany).
Media, cells and viruses
Recombinant baculoviruses expressing the full-length HIV-1 Pr55
Gag (Gag) polyprotein (Ac-Gag) were constructed and propagated as previously described in detail (Wagner et al., 1996b , Smith et al., 1985 . For large scale preparation of recombinant virus-like particles (VLP), HighFive™ insect cells derived from Trichoplusia ni egg cell homogenates (Invitrogen Inc., San Diego, USA) were used for infection with recombinant baculoviruses. Sf9 cells were maintained in TC100 medium (Gibco BRL, Eggenstein, Germany) supplemented with 10% fetal calf serum (FCS), 100 IU of penicillin per ml and 100 μg of streptomycin per ml. HighFive™ cells were propagated in serum-free Insect-Xpress medium (Cambrex, Walkersville, MD) supplemented with 100 μg/ml kanamycin sulfate (PAN, Oberasbach, Germany). All insect cell-lines were maintained at 24 to 27°C.
Purification and biochemical characterization of VLP
HIV-1 Gag virus-like particles (VLP) were produced using the baculovirus expression system as described previously in detail (Wagner et al., 1996b) . In brief, VLP were expressed by infection of HighFive™ cells with the recombinant baculovirus Ac-Gag at a multiplicity of infection (m.o.i.) of 10. After 3 days of infection VLP were pelleted from precleared cell culture supernatants (2000 ×g , for 10 min at 4°C) by sedimentation through a 30% sucrose cushion at 100,000 ×g for 2.5 h at 16°C. Pelleted antigen was allowed to resuspend overnight in PBS, pH 7.5 and VLP were further purified by separation on 10-50% sucrose gradients and subsequent dialysis of combined antigenic peak fractions against PBS (Wagner et al., 1994) . Analysis of pooled antigenic peak fractions of VLP was performed by separation on a 12.5% denaturing sodium-dodecyl sulfate (SDS) polyacrylamide gel followed by Coomassie staining. The identity of the produced particles was verified by immunoblotting. For that purpose proteins were transferred from SDS gels to nitrocellulose membranes (Millipore, Bedford, MA01730, USA) by electroblotting in a transfer buffer (25 mM Tris, 190 mM glycine, 20% methanol). The Gag polyprotein was labeled specifically by sequential incubation with a 1:2000 dilution of the HIV-1 p24-specific monoclonal antibody 13-5 (Wolf et al. 2008 ) and a 1:1000 dilution of an alkaline phosphatelabeled goat anti-mouse immunoglobulin G (Bio-Rad Laboratories, Munich, Germany). Proteins were visualized using a NBT/BCIP solution (0.3% 4-nitro-blue-tetrazolium-chloride (NBT), 0.3% 5-bromo-4-chloro-3-indolyl-phosphate (BCIP), 100 mM Tris, 100 mM NaCl, 50 mM MgCl 2 , pH 9.5). Yields of produced VLP were calculated using a Biorad protein assay (Bio-Rad Laboratories, München, Germany).
Electron microscopy
Supernatants of Ac-Gag-infected High Five™ cells were clarified by centrifugation at 500 ×g for 10 min at 4°C and then centrifuged through 30% (w/v) sucrose cushions for 2.5 h at 100,000 ×g and 16°C. The pelleted antigens were dissolved in PBS without bivalent ions and centrifuged on 10 to 50% (w/v) sucrose gradients at 100,000 ×g for 16 h at 4°C followed by fractionation. Gag-rich fractions were subjected to electron microscopic analysis. Therefore, the sample suspension was shaken gently, approximately 30 μl drops were retrieved and placed on clean parafilm sheets. Formvar-and carbon-coated positively glowdischarge treated cupper grids were incubated on the top of the suspension droplets for 10 min and subsequently blotted dry with a filter paper. After a washing step of 15 s on a droplet of aqua bidest., the grids were blotted again and air-dried for 10 min. Subsequently, each sample was negative stained with 2% aqueous phosphotungstic acid (pH 7.2) for 1 min using the droplet technique and air-dried for at least 30 min. The samples were examined in a LEO912AB electron microscope (Zeiss, Oberkochen/Germany) operating at 80 kV, equipped with a bottom-mounted CCD-camera capable of recording images with 1 k × 1 k pixels. The documentation was done with the iTEM-software, Ver. 5.0 (Olympus Soft Imaging Solutions GmbH, Muenster/Germany).
Titration of baculoviruses by plaque assay
A plaque assay in a 6-well plate format was used to determine the titer of baculoviruses. Therefore 2 × 10 6 Sf9 cells were seeded in each well of two Multiwell™ 6-well plates (Falcon, Becton Dickinson Labware) and allowed to settle down at the bottom of the plates during 2 h of cultivation at 25°C. Cells were infected with serial 10-fold dilutions of test samples and incubated for 30 min at 25°C on a rocking plate. Then, medium was replaced with 2 ml plaquing medium (40% TC 100 2× medium, 10% FCS, 1% PenStrep, and 50% of 3% (w/w) soft agar). Then, cells were incubated for 3 days at 25-27°C, and a neutral red agarose overlay (40% TC 100 2x medium, 10% FCS, 6% neutral red solution (2 g neutral red, 250 ml of 75% ethanol), 1% PenStrep, and 50% of 1.8% (w/w) softagar was added to each well. Then cells were incubated for additional 7-9 days until plaques became visible. The viral titer was calculated by multiplying the number of plaques by the dilution factor and was indicated as plaque-formingunits (pfu) per ug VLP. Freshly produced Gag-particles included approximately 1.44 × 10 6 infectious baculoviruses (pfu)/μg VLP, as determined by plaque titration.
Isolation of monocytes from human blood and determination of cellular activity by an MTS assay
Buffy-coats were obtained by centrifuging whole blood samples from healthy, HIV-seronegative donors for 15 min at 430 ×g and room temperature with the brake off. Human PBMC were isolated from buffy-coats by density gradient centrifugation using Biocoll (Biochrom, Berlin) and cultivated in complete RPMI medium (Invitrogen, Carlsbad, USA) containing 10% heat inactivated FCS (Sigma, St. Louis) and 2 mM L-glutamine (Invitrogen) at 37°C in a humidified 5% CO 2 atmosphere. To isolate monocytes, Petri dishes were coated with sterile 2% gelatine solution (Merck, Darmstadt) for 2 h at 37°C followed by incubation with autologous plasma for 30 min at 37°C. PBMC were loaded onto gelatine/plasma-coated plates at 4 × 10 6 cells/ ml. After 40 min of incubation at 37°C peripheral blood lymphocytes (PBL) were washed out with medium and the adherent monocytes were detached with 5 mM EDTA (Invitrogen) and further cultured in complete RPMI medium. Fluorescence-activated cell sorter (FACS) analysis revealed that the obtained cell population regularly consisted of 96-98% monocytes (see Fig. 8B ). The mitochondrial activity of cells was analysed using a commercially available test kit according to the manufacturer's instruction (Promega, Madison, USA). Briefly, PBMC or monocytes were incubated either with VLP or the corresponding amounts of baculoviruses, which are present in VLP-pulsed cells. At indicated time points 3-(4,5-dimethylthiazol-2-yl)-5(3-carboxymethonyphenol)-2-(4-sulfophenyl)-2 H tetrazolium (MTS) was added to the cells and the conversion of the substance by active mitochondrial enzymes was measured in an ELISA reader by determining the optical density (OD) at dual wavelengths of 492 nm to 620 nm.
Determination of cytokine expression by VLP-pulsed cells
PBMC or monocytes were seeded at 1 × 10 6 cells/ml in RPMI 1640 medium containing 10% FCS, 1% penicillin-streptomycin (Invitrogen) and cultured in presence or absence of various VLP concentrations. As control, cells were incubated with baculovirus at concentrations corresponding to that in the VLP preparations. For some experiments, cells were incubated with VLP, which had been pre-treated with a 1:10 dilution of normal human serum (NHS), followed by addition of 18 mM EDTA. Cell-free culture supernatants were collected and the content of individual cytokines was tested by ELISA. Therefore, ELISA plates were coated overnight at 4°C with 2 μg/ml capture antibody followed by washing with PBS/0.1%Tween-20 and incubation with culture supernatants for 1 h at room temperature. After subsequent washing the biotinylated detection antibody was added for 1 h at a concentration of 500 ng/ml. After 3 washings, the plates were incubated for 1 h at 37°C with avidin-horseradish peroxidase conjugate (DAKO, Vienna). After 4 final washes, the plates were developed with tetramethylbenzidine dihydrochloride (Sigma) for 5 min. The reaction was stopped with 2 M H 2 SO 4 , and the optical density (OD) was measured at dual wavelengths of 450 to 620 nm.
FACS analysis of surface molecule expression
After the appropriate incubation time, antigen-pulsed cells were pre-treated with 0.5% trypsin/0.2% EDTA for 10 min to detach adherent cells and were washed twice with PBS/0.5% BSA. To measure cell surface expression of proteins, cells were incubated with 5 μg/ml of the appropriate specific antibody or unspecific IgG as isotype control for 30 min at 4°C, washed again with PBS/BSA and then stained with a second FITC-labeled antibody (DAKO). Analyses were performed using a FACScan flow cytometer (Becton Dickinson, San Diego).
